What Financial Administrators Must Know About Clinical Research at MSU
|
|
|
- Patrick Griffith
- 10 years ago
- Views:
Transcription
1 What Financial Administrators Must Know About Clinical Research at MSU Philip Reed, Interim Director CTSI & Director of BRIC, Clinical & Translational Sciences Institute Ann Smith, Operations Administrative Manager, Clinical & Translational Sciences Institute 1
2 Vice President for Research & Graduate Studies Clinical & Translational Sciences Institute (CTSI) Biomedical Research Informatics Core (BRIC) Develop New Opportunities With Research Partners Office of Clinical Research (OCR) BRIC s Research Portfolio: CDC, DOD, NIH, Trinity Health Data Mgt. & Informatics Support of Funded MSU- PI Projects Budget Review, Development & Negotiation Services Clinical Trials: Find Trials for Departments CTSI-Based Trials Support Dept.- Based Trials Investigator Support in New Grant Application Development PI & Staff Training in Study Execution & Compliance Research Facilitation & Interdepartment al Liaison 2 Personnel & Lab Support Services
3 3 Clinical Research Interface Touch Points
4 What is Clinical Research? Human Research Clinical Research Clinical Trials Investigator Initiated Industry Sponsored 4
5 Clinical Research is a Business Clinical Research is a BUSINESS and must be run accordingly! A Business best achieves goals by starting with a STRATEGIC PLAN 5
6 Clinical Research Strategic Planning Why are you in the business of clinical research? What is your market? What are your research fixed operating costs, and how will you fund them through clinical research? How will you attract and retain high-quality staff? 6
7 Use of Business Tools Operational Budgets Project Budget Templates Breakeven Analysis Protocol Feasibility Clinical Research Management Systems 7
8 Presents a Win/Win/Win Opportunity Generates revenues to support equipment, personnel and other resources Provides access to state-of-the-art therapies, devices and techniques 8
9 The Challenge: Clash of Cultures Industry s Culture Profit-oriented Protection of proprietary data Swift moving Results oriented 9
10 The Challenge: Clash of Cultures University s Culture Non-profit Values dissemination of ideas Values deliberation and consensus Primary responsibility is to the public 10
11 The Business of a Research Study A Clinical Research Study is Type of Virtual Company It has Similarities with a Movie Production Company 11
12 What and Who are Involved? Principal Investigators Other Compliance staff (IRB, Human Subjects Liaisons The Process Sub- Investigators 12 Administration (Contracts, Budget & Billing) Study Staff (Coordinators, Nurses, Data Managers) Ancillary Services
13 Protocol Feasibility Overview Know your subject base and have recruitment plans Be aware of project logistics and available resources Be aware of financial obligations of the study Is the research important to the Department/College? Beware of over-enthusiastic PIs 13
14 Who Processes Agreements at MSU All Industrial Sponsored Clinical Trials & Research Agreements are handled by MSU Business Connect, Randy Sheets All Federally Sponsored or Non-Profits Clinical Trials & Research Agreements are handled by the Office of Sponsored Programs, Fred Salas Appropriate application of the clinical trial F&A cost rate 26% of direct costs for Industrial Sponsored Trials 53.5% for federally sponsored investigator-initiated research Other rates 14
15 Issues in the Business of Clinical Research FDA reports nearly 4,000 active investigational new drug applications in clinical trials at any one time Only 14% of studies are completed on time 81% of studies are delayed six months or more Pharmaceutical Companies under intense competitive pressures R&D budgets increased by 14% to 16%/ year; but study budgets have remained flat In 1994, 76% of clinical research was conducted in the academic setting; in % is done in universities 15
16 The Challenge: It Takes To Long Time from Confidential Disclosure Agreement (CDA) to First Patient Enrolled Industry Goal 90 days Universities 180 days MSU 270 days 16 CDA 1 st Patient Enrolled
17 Simultaneous Institutional Evaluation (Pre-Award) Department / College Approvals Submit for Review by CTSI Contract Rev by Appropriate Office Submit IRB Application Additional Required Reviews? Obtain All Needed Institutional Reviews &/or Approvals, CGA Account Setup, & Notify All Parties 17
18 18 Budget Preparation and Negotiation
19 Budget Objectives Analyze the Protocol and determine the study services Identify costs for services Create overall study budget Upfront/Start Up Costs Per Subject Costs Fixed Costs Produce Study Billing Grid Negotiate Budget and Payment Terms (Contract) 19
20 Typical Budget Components Study Effort/Personnel Costs Upfront/Start Up Costs IRB fees Per subject (variable) costs pharmacy, imaging, labs, regulatory prep and amendment fees, Safety report review fees, supplies, record archiving Ongoing Administration Expenses Facilities and Administrative Costs (F&A) assessed on all items except IRB fees 20
21 Tips on what to look for when Analyzing the Protocol for Study Costs Identify each event to occur at each study visit Do not rely solely on the schedule of events Include costs for ancillary services required by the protocol Include hidden and personnel costs Identify open enrollment period for inflation factor 21
22 Cost Sources Start-up admin fee - PI Protocol Review - IRB Preparation - Budget Preparation - Study Coordinator - Administrative Staff - Investigator and site initiation meeting IRB Submission Research Pharmacy (set-up and close out) Telephone, Fax, Office Supplies Records Archiving Equipment Training Study management and maintenance- - Monitoring visits, data queries - Sponsor contact (teleconferences, meetings, s) - Financial management - Supply and Pharmacy drug/device management -Reporting - Regulatory submissions (revisions, renewals, SAE reporting) Study close out - Data queries - Drug / device return - Financial reconciliations 22
23 The Budgeting Process Tools Available to Assist You Office of Clinical Research (OCR) Review Budgets, Clinical Trial Agreement (CTA) payment language Assist with analyzing MSU costs vs Sponsor payment Negotiate Clinical Trial/Research Budget Costs w/ Sponsors Clinical Research Management System Access currently Merge CRMS 23 Access to Study Staff for purchase on a percent FTE for investigators just getting started who do not have own staff
24 Billing Compliance & Medicare Coverage Analysis 24
25 Overview of Billing Rules Many rules govern the billing Process False Claim Act Erroneous Billing Stark I, II & III Anti-Kickback Act Medicare Rules Patient Protection and Affordable Care Act (PPACA) State Insurance Regulations Institution Policies 25
26 IMPORTANT: Pitfalls to Avoid Need to have a Medicare Coverage Analysis done to ensure no inadvertent double billings occur A variety of information must be coordinated across many MSU departments to manage research billing compliance Verify Cost are Covered Communication should be done as early in the process as possible to manage compliance risks Office of Clinical Research is available to help units with both of these processes 26 Adapted from materials presented by Meade & Roche LLP at HCCA Research Basic Compliance Academies, Aug 15-18, 2011, Las Vegas
27 Billing Grid Details each study visit activity and related charges Created as part of the budgeting process Billing Grid illustrates how procedures will be charged Standard Of Care (SOC)- Procedures/items are routine and are to be paid by patient s insurance or Third Party Payer Research-Related Procedures and Activities 27
28 Billing Grid Example 28 28
29 Clinical Research Billing Risks Double Billing billing for services that are already paid for by sponsor to a Third-Party Insurance Billing for services that in the informed consent indicated would be at no cost to the participant Billing for services that are research only Billing for services that are part of a non-qualifying clinical trial, Medicare is not willing to pay for all standard of care for all studies. 29 Adapted from materials presented by Meade & Roche LLP at HCCA Research Basic Compliance Academies, Aug 15-18, 2011, Las Vegas
30 Why Do We Care? ETHICAL, LEGAL & PR CONSIDERATIONS 30
31 Office of Inspector General - False Claims Kevin Cosens (Device salesman) Qui Tam Action Inappropriate billing of non-fda approved cardiac devices 31 Over 130 major academic medical centers and community hospitals named over 40 still being actively pursued 34 previous settlements recovering $45 million Larger Settlements: University of Washington $3.6 million University of California SD $4.7 million Allegheny General Hospital $3.2 million Catholic Healthcare West $10.8 million In addition, most of these hospitals are now operating under Cooperate Integrity Agreements
32 Other False Claims Settlements (Research-related) The Methodist Hospital (Houston) St. Luke s Episcopal Hospital (Houston) Deaconess Medical Center (Spokane) Legacy Good Samaritan Hospital (Portland) Orlando Regional Medical Center (Orlando) Scripps Health (La Jolla, San Diego) UPMC Health System (Pittsburgh) INTEGRIS Baptist Med Center (Oklahoma City) Hoag Hospital (Newport Beach) St. Joseph s Regional Medical Center (South Bend) Beth Israel Deaconess Medical Center LDS Hospital (Salt Lake City) Holy Cross Hospital (Ft. Lauderdale) Miami Heart Institute (Miami) $2.75 million $575,000 $775,000 $410,000 $390,000 $3.8 million $1.5 million $629,000 $305,000 $107,000 $3.2 million $850,000 $2.8 million $1.9 million 32
33 33 Financial Management
34 Pre-Award Financial Management Budget development & internal costing Subcontract budget development if needed Billing grid generation for proper billing (3 rd party for routine vs study funds for research-related charges) Post-Award Track sponsor payments; review for accuracy Invoicing sponsor for line items Payables to service providers per billing grid Labor distributions & effort reporting Study subject stipends and 1099 Subrecipient Monitoring Study closeout of finances 34
35 Automatic Payments (ACH/Check) Payments generated upon completion of study events Payments trigger by either data entry or monitoring visits Payment notification goes to departments for correct payment verification 35 CGA cash management group needs to be notified notification of ACH deposit and study title, account number, amount and type of payment (i.e. per subject payment, invoiceable, or start-up) Cover letter containing the information above to accompany check when dropped off at CGA
36 Invoicing Items that are not automatically paid Invoices are generated by site, needs close monitoring for payment by sponsor and to ensure credit to your account. Units need a system to track invoices & reconcile payments received 36
37 37 Be aware of partial payments Sponsor may only pay a portion of an invoice due to many items, which may include: -Payment withholds until end of study -Prorated payment due to study milestones -Case Report Form issues: incomplete, delayed, unverified - Not all study procedures may have been performed -Subject withdrawal
38 38 Accounts Payable Payments for ancillary services Either by subcontract or purchase order for external providers For internal providers, via EBS as internal bill to the res. account Examples of Subcontracts (are considered engaged in research) Sparrow Pharmacy Hospital Bed Fees Examples of Purchase Orders (services providers) Sparrow Laboratory testing, Research Pharmacy services, imaging services Internal Service Providers IRB Fees MSU Imaging Services Cardiology Services MSU Pharmacy
39 Subject Stipend Payments Stipend: Payment to subject for reimbursement of study-related effort and expense. Dispensation of stipends must be tracked Cash Management Checks Privacy Compliance Internal Control Mechanisms Sensitive data should not be listed in 39 the EBS system when paying participants
40 In Summary Proactive fiscal administration enhances billing compliance! Develop Billing Grid Track subject enrollment & visits Reconcile research services against billing grid 40
41 41 Questions?
ROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Study Start-up
Office of Research Administration: Clinical Research Contracting
Office of Research Administration: Clinical Research Contracting Presented to: Research Administration Professionals Group Presented by: Patricia Travis and Mont Brownlee October 22, 2013 1 Training Agenda
The Study Site Master File and Essential Documents
The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010
Vertex Investigator-Initiated Studies Program Overview
Vertex Investigator-Initiated Studies Program Overview Our Goal To support independent, investigator-initiated research designed to advance scientific knowledge of disease states, patient populations,
The Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis
The Monitoring Visit Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis Disclosure The information herein is not intended to
Fundamentals of Clinical Trial Financial Management
Fundamentals of Clinical Trial Financial Management Lindsey Spangler Michelle Smith COURSE OBJECTIVES Understand the life cycle of a clinical study from a financial perspective Understand the purpose of
Industry Clinical Trials: Budgeting and Expense Management
School of Medicine Alan P. Venook, MD Professor of Clinical Medicine Suzanne Sutton Director of Research Administration Industry Clinical Trials: Budgeting and Expense Management The UCSF Experience Industry
Introduction to Clinical Research
Introduction to Clinical Research NCURA Region I Spring Meeting May 5, 2015 Agenda Introductions Brief History of Clinical Research Clinical Research in Context Clinical Research Compliance Clinical Research
NEGOTIATING CLINICAL TRIAL BUDGETS. Debbie Williams R.N., C.C.R.C., C.R.A., A.B.N.
NEGOTIATING CLINICAL TRIAL BUDGETS Debbie Williams R.N., C.C.R.C., C.R.A., A.B.N. A.B.N. Amateur Budget Negotiator OVERVIEW Budget Types Analyzing the Protocol Negotiating the Contract Discussion / Tips
Review current regulatory climate Budget development Coverage analysis Charge reconciliation / 3 rd party billing Lessons learned
Meeting the Challenge of Compliant Clinical Research Billing Kathy Hammerhofer, BSN, RN Kelly Nottingham, MPH, CHES Objectives Review current regulatory climate Budget development Coverage analysis Charge
Clinical Research Billing Process
Clinical Research Billing Process Office of Inspector General priorities Inappropriate clinical research billing Double dipping Residual funding of federal funds Effort reporting Draft OIG Compliance Program
Clinical Trials Budgeting and Billing
Clinical Trials Budgeting and Billing Presented by: Ellen N. Jamieson, MS, MBA Director, Grants Administration Alexandria Hui, BA Manager, Clinical Trial Financial Analyst Rules and Regulations Medicare
Children s Research Management System (CRMS) Version 3.0. Children s Hospital Colorado Research Institute Training Guide April 2015
Children s Research Management System (CRMS) Version 3.0 Children s Hospital Colorado Research Institute Training Guide April 2015 Table of Contents Operational Needs Assessment (ONA) 3 Visit Schedules
Clinical Trial Center
Clinical Trial Center QUALITY The mission of the Clinical Trial Center (CTC) is to facilitate the timely execution of quality clinical trials with information, resources and expertise in order to foster
GRANT AND CONTRACT ACCOUNTING GRANT REVIEW TOOLKIT POST AWARD PROCESS
The below information is a brief overview of the Post Award Process that Grant and Contract Accounting follows in its post award administration of awarded sponsored projects. Please note that this overview
The Clinical Trials Office: Understanding Organizational Structure, Functions through a Real-World Lens
The Clinical Trials Office: Understanding Organizational Structure, Functions through a Real-World Lens August 27 th 2015 YOUR MISSION OUR SOLUTIONS Huron Consulting Group Inc. All Rights Reserved. Huron
Essential Documents for the Conduct of a Clinical Trial. Debra Dykhuis Associate Director RSO
Essential Documents for the Conduct of a Clinical Trial Debra Dykhuis Associate Director RSO Introduction Rationale for choosing this topic AHC movement toward setting GCP (Good Clinical Practice) guidelines
CLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES
CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES 1. Clinical Study Team Principal Investigator Co Principal Investigator (Co PI) Research Coordinator Study Monitor Data manage Sponsor Post Doctoral Scholar
CLINICAL RESEARCH GENERIC TASK DESCRIPTIONS
Purpose Purpose Purpose Primary responsibility for implementation, coordination, evaluation, communication and/or management of research studies. May involve more than one study or multiple sites within
Cheryl K. Bernstein RN, BSN, CCRC Director Bernstein Clinical Research Center, LLC Cincinnati, Ohio [email protected]
Cheryl K. Bernstein RN, BSN, CCRC Director Bernstein Clinical Research Center, LLC Cincinnati, Ohio [email protected] Identify and discuss the language used in reciprocal or crossed indemnification and
2. For all clinical trials, the coverage analysis will also be audited to ensure compliance with the Medicare National Coverage Determination.
COMPLIANCE PROGRAM POLICY: Clinical Research Billing Audit Policy Effective Date: August 1, 2014 Last Updated: Page 1 of 8 I. POLICY All UC Irvine Health departments engaged in clinical research may be
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives
Medical Billing Human Research Studies Seminar Notes
Audits If a department learns that an external audit is going to be initiated, the Billing Compliance Department and Research Administration should be notified when the scope of the audit involves billing
Budgets and Financial Monitoring Tools and Tips. January 21, 2014
Budgets and Financial Monitoring Tools and Tips January 21, 2014 Overview Setting the stage with regulatory framework Circulars and general ideas and principles behind them Changes to OMB with the recently
Comprehensive Study Documents List (Biomedical Studies)
Comprehensive Study Documents List (Biomedical Studies) Investigators conducting human subjects research must maintain study documents in adherence to federal and state regulations, USC policies, and good
Orientation Manual for Clinical Research Coordinators
Orientation Manual for Clinical Research Coordinators Maine Medical Center Research Institute Page 1 of 19 Version 1 (2009) MAINE MEDICAL CENTER RESEARCH INSTITUTE Statement of Mission, Vision, Goals and
DHHS/NIH/OD/OIR/OHSRP 1/2/2015
DHHS/NIH/OD/OIR/OHSRP 1/2/2015 The audience for this course is Principal Investigators (PIs), investigators and Research Coordinators (RCs) serving on the study team of human clinical studies and trials.
Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: [email protected]
SAMPLE CRA CV Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: [email protected] Education: Masters of Science, Healthcare Administration, Capital City University,
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
Principal Investigator and Sub Investigator Responsibilities
Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal
This policy applies to all clinical research conducted at Beaumont Health System.
CLINICAL RESEARCH QUALITY AND PROCESS IMPROVEMENT PROGRAM 113 1 of 6 PURPOSE Prior The purpose of this policy is to provide an overview of the Clinical Research Quality and Process Improvement Program
Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health
Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health We are responsible for acquiring, analyzing, and protecting medical information vital to providing quality patient care HIM professionals ensure
Office of Clinical Research (OCR)
Office of Clinical Research (OCR) Your Partner in the Clinical Research Process h3p://bsdocr.bsd.uchicago.edu Phone: 834-1238 Susan L. Cohn, MD Dean for Clinical Research Professor of Pediatrics OCR Created
Seven Component Framework For Compliance Auditing & Monitoring Physician Contracting In Healthcare Organizations
Seven Component Framework For Compliance Auditing & Monitoring Physician Contracting In Healthcare Organizations Author: Debi J. Weatherford, Vice President, Compliance and Audit Services, Revenue Cycle
OnCore Clinical Research Management System Standard Operating Procedures
Purpose: This standard operating procedure (SOP) provide definitions for terms used in the OnCore clinical research management system at Georgia Regents University (GRU). 2.0 Scope: Applies to all site
UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM. DoD/DON-funded Research
UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM DoD/DON-funded Research Policy In 2006, the Department of the Navy (DON) enhanced its human subject protection requirements, including
Office of Research Administration Clinical Research Support Services
Office of Research Administration Clinical Research Support Services 1629 S. Thames Street, Suite 200 Baltimore, Maryland 21213 410-502-6001/office 410-502-6004/fax [email protected] 1 Office Organization
Classifying Adverse Events From Clinical Trials
Classifying Adverse Events From Clinical Trials Bernard LaSalle, Richard Bradshaw University of Utah, Biomedical Informatics, Salt Lake City, UT USA [email protected] Abstract The use of adverse
HIPAA Privacy Board Overview
Defense Health Agency Privacy and Civil Liberties Office HIPAA Privacy Board Overview April 30, 2015 1 Objectives The purpose of this presentation is to: Provide an overview of the DHA Privacy and Civil
Coverage Analysis: The Cornerstone of Clinical Research Billing Presented by: Mary L. Veazie, CPA, MBA, CHC, CHRC Executive Director, Clinical
Coverage Analysis: The Cornerstone of Clinical Research Billing Presented by: Mary L. Veazie, CPA, MBA, CHC, CHRC Executive Director, Clinical Research Finance The University of Texas MD Anderson Cancer
Office of Clinical Research and the. Institute (CTSI) Patricia Emmanuel, MD
Office of Clinical Research and the Clinical and Translational Research Institute (CTSI) Patricia Emmanuel, MD Office of Clinical Research- Priorities Review processes for clinical study implementation,
Clinical Investigator Inspections and FDA-483 Observations
Clinical Investigator Inspections and FDA-483 Observations Nancy A. Bellamy, Investigator Bioresearch Specialist/ BIMO Coordinator FDA Detroit District Office October 2, 2013 Objectives Background on FDA
Annex A. Levels 1 5 of the Clinical Research Coordinator Track in the Clinical Research WSQ Framework
Annex A Levels 1 5 of the Clinical Research Coordinator Track in the Clinical Research WSQ Framework WSQ Higher Certificate in Clinical Research (Clinical Research Coordinators) Apply Drug Development
ROBERT SALCIDO CONFERENCE PRESENTATIONS
ROBERT SALCIDO CONFERENCE PRESENTATIONS Maryland, Topic: The Compliance Conundrum: What to Do When a Potential Whistleblower Appears in Your Office? (Sept. 30-Oct. 2, 2012). American Bar Association s
Principal Investigator Responsibilities for Education and Social/Behavioral Researchers
Principal Investigator Responsibilities for Education and Social/Behavioral Researchers Introduction The purpose of this module is to provide a basic understanding of the responsibilities of the principal
September 20, 2012. Kelly Willenberg, MBA, BSN, CHC, CHRC. Kelly Willenberg, LLC
September 20, 2012 Kelly Willenberg, MBA, BSN, CHC, CHRC 1 1 Understand the importance of research billing compliance and how that impacts the hospital and your practice Understand how billing can advance
CONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator
Research Department STANDARD OPERATING PROCEDURE STH Investigator Archiving of Essential Documentation Generated During Clinical Research SOP Number A127 Version Number V1.3 Effective Date Author Zoe Whiteley
W. Kenneth Davis Jr.
W. Kenneth Davis Jr. Partner +1.312.902.5573 [email protected] 525 West Monroe Street Chicago, IL 60661-3693 Practices Mergers and Acquisitions Corporate Private Equity Industries FOCUS: Health Care
ICH CRA Certification Guide March 2009
ICH CRA Certification Guide March 2009 ICH CRA CERTIFICATION GUIDE... 1 GENERAL INFORMATION... 2 BENEFITS OF CERTIFICATION... 2 INDUSTRY RECOGNITION... 2 ABOUT THE EXAM... 2 CRA DEFINITION... 2 REQUIREMENTS
To Certify or Not to Certify
To Certify or Not to Certify Sandra Halvorson, BA, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus Sue Logan, BS, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus November
To Certify or Not to Certify Sandra Halvorson, BA, CCRP
To Certify or Not to Certify Sandra Halvorson, BA, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus Sue Logan, BS, CCRP Clinical Research Coordinator II We have no financial relationships
Determining who the investigators are and who the principal investigator is:
Responsibilities of the IRBs of the Health System and University for Research Conducted by Investigators from a Combination of the Following Institutions: the Health System, University, and Medical School
Regulatory Binder Instructions 25 April 2016
Regulatory Binder Instructions 25 April 2016 Instructions This Regulatory Binder is available to help study sites achieve and maintain regulatory compliance and adhere to high standards of practice in
Research Master Trial Agreement
November 2010 FDP Institution/Organization ("Prime Recipient") (National Coordinating Center ( NCC ) Institution/Organization ("Subrecipient") (Regional Coordinating Center ( RCC ) Name: University of
UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM HUMAN SUBJECT PROTECTION TRAINING
UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM A. General Information HUMAN SUBJECT PROTECTION TRAINING UCSD Institutional Review Board (IRB) human subject protection training has
UT Health Science Center at San Antonio Research/Grant Records
UT Health Science Center at San Antonio Research/Grant Records Agency 1.1 Administrative Records - General 400 DE Experiments and Tests. AV O False SEE section on Medical/Dental - Patient Records, record
Christopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration
Christopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration Clinical Research Center Learn-At-Lunch Series October 13, 2011
How To Write A Binder Tab
Tool Summary Sheet Tool: Extramural Essential Documents Binder/File Tabs Purpose: To provide an organizational framework and guidance for filing paper versions of essential study documents (or referencing
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems to support collection, cleaning and management of subject
Quality Monitoring Checklist
Quality Monitoring Checklist Instructions: For each task below, the Quality Monitor indicates in the appropriate column if the Monitor accomplished the task by using the following codes Yes No N/A = Monitor
ROLE OF CONTRACT MANAGEMENT IN A HEALTHCARE COMPLIANCE PROGRAM DESIGN
ROLE OF CONTRACT MANAGEMENT IN A HEALTHCARE COMPLIANCE PROGRAM DESIGN John Riley Vice President of Sales MediTract, Inc. Session Overview Overview of Compliance Regulations affecting Contract Management
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry By http://www.clinicalresearchassociate cra.com/studyguide/ A clinical research associate (CRA) is a
An introduction to Research Management and Governance (RM&G) in the NHS
An introduction to Research Management and Governance (RM&G) in the NHS Rachel Davis Assistant RM&G Project Manager Natassia Embury R&D Facilitator 14/04/2014 Delivering clinical research to make patients,
Records and Clinical Trials
Integrating Electronic Health Records and Clinical Trials The Children s Hospital An Examination of Pragmatic Issues Affiliated with University of Colorado Health Sciences Center Denver, Colorado Michael
A Clinical Research Coordinator for an International Study THE GYMNAST
A Clinical Research Coordinator for an International Study THE GYMNAST Anita Ng Research Coordinator The Scarborough Hospital May 12, 2007. 1. What is Research? 2. Characteristics of a Clinical Research
The Pediatric Research Center. Clinical Research Center Introduction and Study Submission Guidelines
The Pediatric Research Center Clinical Research Center Introduction and Study Submission Guidelines PRC Leadership Anne Fitzpatrick, PhD, MSCR, APRN Program Director of the PRC Assistant Professor, Pediatric
The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations
The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations Maria Luisa Paoloni OPBG Clinical & Research Services Monitoring and Responsible of monitoring:
TEMPLATE DATA MANAGEMENT PLAN
TEMPLATE DATA MANAGEMENT PLAN ICRIN (QM sub group) Version: XX Date: XXXXXXX Page 1 of 6 1.0 Document Ownership The Data Management Plan (DMP) will be initiated and subsequently owned by the Data Manager
Remote Monitoring of Clinical Trials and EMRs
Remote Monitoring of Clinical Trials and EMRs Sandra SAM Sather, MS, BSN, CCRA, CCRC Vice-President Clinical Pathways LLC [email protected] Lindsey Spangler, J.D. Associate Director,
Clinical Research Management Webinar Series: How to Process Medicare Advantage Claims for Research Billing
Clinical Research Management Webinar Series: How to Process Medicare Advantage Claims for Research Billing Wednesday, September 19, 2012 12:00 p.m. - 1:00 p.m. CT About Our Speakers Allecia A. Harley Director,
Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010
Medicare Advantage and Part D Fraud, Waste, and Abuse Training October 2010 Introduction 2008: United States spent $2.3 trillion on health care. Federal fiscal year 2010: Medicare expected to cover an
Clinical Trials: The Crux of Cancer Innovation
Clinical Trials: The Crux of Cancer Innovation Even as medical science is transforming cancer care, major deficiencies in the way cancer clinical trials are designed, carried out, regulated and funded
Final. National Health Care Billing Audit Guidelines. as amended by. The American Association of Medical Audit Specialists (AAMAS)
Final National Health Care Billing Audit Guidelines as amended by The American Association of Medical Audit Specialists (AAMAS) May 1, 2009 Preface Billing audits serve as a check and balance to help ensure
Coverage Analysis. Purpose
Coverage Analysis Purpose The purpose of this policy is to provide a method for researchers to perform a Coverage Analysis (CA) for clinical research conducted at Mission Hospital, Inc., Memorial and St.
INTERIM SITE MONITORING PROCEDURE
INTERIM SITE MONITORING PROCEDURE 1. PURPOSE The purpose of this SOP is to describe the interim monitoring procedures conducted at Institution, according to GCP and other applicable local regulations.
Debbie M. Craver Brown, RN, MSN Senior Associate Clemmons, North Carolina 336.766.2761 or 336.692.2279 Email: [email protected].
CURRICULUM VITAE Debbie M. Craver Brown, RN, MSN Senior Associate Clemmons, North Carolina 336.766.2761 or 336.692.2279 Email: [email protected] Prior Accomplishments and Experience Deborah Brown
University of Florida College of Medicine Jacksonville
University of Florida College of Medicine Jacksonville Research Overview Alan R. Berger, M.D. Associate Dean, Research Affairs Professor and Chair, Neurology Tina M. Bottini Assistant Dean, Research Administration
